English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/78745
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Down regulation of c-Myc and Max genes is associated to inhibition of protein phosphatase 2A in K562 human leukemia cells

AuthorsLerga, Ana; Belandia, Borja ; Delgado, M. Dolores ; Cuadrado, M. Ángeles; Richard, C.; Ortiz, José M.; Martín-Pérez, Jorge ; León, Javier
Issue Date1995
CitationBiochemical and Biophysical Research Communications 215(3): 889-895 (1995)
AbstractTreatment of the human myeloid leukemia K562 cells with the protein phosphatase inhibitors okadaic acid or calyculin A resulted in down-regulation of both c-myc and max genes at the mRNA and protein levels. The extent of the down-regulation was similar for both genes and was dependent on the dose and on the treatment time. Interestingly, c-myc and max down-regulation was concomitant with apoptosis induced by okadaic acid and calyculin A in K562 cells. The expression of c-myc and max returned to control levels after the removal of okadaic acid from the media, although apoptosis was irreversible. These effects were observed at okadaic acid concentrations (15 nM) that inhibited the activity of protein phosphatase type 2A but not of phosphatase type 1. We conclude that the inhibition of protein phosphatase 2A is associated to decreased levels of c-Myc/Max heterodimers in K562 cells.
Identifiersdoi: 10.1006/bbrc.1995.2547
issn: 0006-291X
Appears in Collections:(IBBTEC) Artículos
(IIBM) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.